CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

RVMD's Revenue Growth by Quarter and Year

Revolution Medicines Inc 's Revenue results by quarter and year




RVMD Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 9.46 8.75 0.00
III Quarter September 3.36 1.10 12.66 0.00
II Quarter June 9.12 8.70 10.03 0.00
I Quarter March 7.58 10.13 11.55 0.00
FY   20.06 29.39 42.99 0.00



RVMD Revenue third quarter 2022 Y/Y Growth Comment
Revolution Medicines Inc achieved in the third quarter 2022, above Company average Revenue surge of 205.09% year on year, to $ 3.36 millions.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 22 other companies have achieved higher Revenue growth. While Revolution Medicines Inc ' s Revenue doubling of 205.09% ranks overall at the positon no. 377 in the third quarter 2022.




RVMD Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 8.11 % - -
III Quarter September 205.09 % -91.31 % - -
II Quarter June 4.83 % -13.26 % - -
I Quarter March -25.17 % -12.29 % - -
FY   - -31.64 % - -

Financial Statements
Revolution Medicines Inc 's third quarter 2022 Revenue $ 3.36 millions RVMD's Income Statement
Revolution Medicines Inc 's third quarter 2021 Revenue $ 1.10 millions Quarterly RVMD's Income Statement
New: More RVMD's historic Revenue Growth >>


RVMD Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 760 % -30.88 % -
III Quarter September -63.2 % -87.36 % 26.22 % -
II Quarter June 20.32 % -14.12 % -13.16 % -
I Quarter March -19.87 % 15.77 % - -
FY (Year on Year)   - -31.64 % - -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #23
Healthcare Sector #75
Overall #377

Revenue Y/Y Growth Statistics
High Average Low
8.27 % -4.51 % -28.73 %
(Sep 30 2022)   (Sep 30 2021)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #23
Healthcare Sector #75
Overall #377
Revenue Y/Y Growth Statistics
High Average Low
8.27 % -4.51 % -28.73 %
(Sep 30 2022)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Revolution Medicines Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
759.22 % 59.3 % -87.34 %
(Dec 31 2021)  


RVMD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Revolution Medicines Inc reported fall in Revenue from the second quarter by -63.2% to $ 3.36 millions, from $ 9.12 millions achived a quarter before.

As we evaluate recent downturn at the III. Quarter, we must presume, that usually III. Quarter performance occur sluggish relative to the second quarter, Fanny Alves, a business observer from Madrid added.

Within Biotechnology & Pharmaceuticals industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Revolution Medicines Inc 's Revenue growth quarter on quarter, overall rank is 2174.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #81
Healthcare Sector #337
Overall #2174
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #81
Healthcare Sector #337
Overall #2174
Revenue Q/Q Growth Statistics
High Average Low
759.22 % 59.3 % -87.34 %
(Dec 31 2021)  


RVMD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Revolution Medicines Inc reported fall in Revenue from the previous quarter by -63.2% to $ 3.36 millions, from $ 9.12 millions achived in the previous quarter.

When you analyse recent shortcoming in the quarter, you must presume, that usually III. Quarter performance appear to be weaker in contrast to the quarter before

Within Biotechnology & Pharmaceuticals industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Revolution Medicines Inc 's Revenue growth quarter on quarter, overall rank is 2174.


Revolution Medicines Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 29.51 $ 27.26 $ 26.84 $ 29.39 $ 28.68
Y / Y Revenue Growth (TTM) 2.89 % -32.27 % -35.44 % -31.62 % -
Year on Year Revenue Growth Overall Ranking # 1477 # 2625 # 3013 # 3459 # 0
Seqeuential Revenue Change (TTM) 8.27 % 1.56 % -8.69 % 2.47 % -28.73 %
Seq. Revenue Growth (TTM) Overall Ranking # 377 # 1804 # 3171 # 2204 # 3632




Cumulative Revenue growth Comment
With 2.89% annual Revenue growth, Revolution Medicines Inc would report a record annual Revenue improvement if the fiscal year would end on Sep 30 2022.

In the Healthcare sector 186 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1477, from total ranking in previous quarter at 2625.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.27 %
-4.51 %
-28.73 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 187
Overall # 1477

Revenue TTM Y/Y Growth Statistics
High Average Low
2.89 %
-24.11 %
-35.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 75
S&P 500 # 377
Cumulative Revenue growth Comment
With 2.89% annual Revenue growth, Revolution Medicines Inc would report a record annual Revenue improvement if the fiscal year would end on Sep 30 2022.

In the Healthcare sector 186 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1477, from total ranking in previous quarter at 2625.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.27 %
-4.51 %
-28.73 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 187
Overall # 1477

Revenue TTM Y/Y Growth Statistics
High Average Low
2.89 %
-24.11 %
-35.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 75
S&P 500 # 377




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RVMD's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RVMD's Competitors
Revenue Growth for Revolution Medicines Inc 's Suppliers
Revenue Growth for RVMD's Customers

You may also want to know
RVMD's Annual Growth Rates RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio
RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons



Companies with similar Revenue improvement for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Rvl Pharmaceuticals Plc356.38%$ 356.375 millions
One World Products Inc 325.40%$ 325.405 millions
Ardelyx inc 325.06%$ 325.064 millions
Rhythm Pharmaceuticals inc 316.73%$ 316.732 millions
Eton Pharmaceuticals Inc 315.35%$ 315.355 millions
Novavax inc 310.74%$ 310.736 millions
Apellis Pharmaceuticals Inc 290.37%$ 290.372 millions
Aurinia Pharmaceuticals Inc 280.30%$ 280.303 millions
Sera Prognostics Inc 278.26%$ 278.261 millions
Mirum Pharmaceuticals Inc 275.60%$ 275.600 millions
Fresh Tracks Therapeutics Inc 268.18%$ 268.182 millions
Vir Biotechnology Inc 261.49%$ 261.486 millions
India Globalization Capital Inc 260.71%$ 260.714 millions
Arcus Biosciences Inc 254.94%$ 254.941 millions
Ideaya Biosciences Inc 230.87%$ 230.871 millions
Arvinas Inc 226.34%$ 226.340 millions
Intra cellular Therapies Inc 223.63%$ 223.634 millions
Orbital Infrastructure Group Inc 222.85%$ 222.850 millions
Revolution Medicines Inc 204.81%$ 204.814 millions
Harpoon Therapeutics Inc 203.68%$ 203.680 millions
Scynexis Inc 201.74%$ 201.744 millions
Vbi Vaccines Inc196.26%$ 196.262 millions
Sutro Biopharma Inc 195.26%$ 195.257 millions
Statera Biopharma Inc fka Cytocom Inc 183.48%$ 183.475 millions
Bolt Biotherapeutics Inc 180.85%$ 180.851 millions
Geron Corp172.48%$ 172.477 millions
Xeris Biopharma Holdings Inc 168.76%$ 168.761 millions
Albireo Pharma inc 168.34%$ 168.341 millions
Aligos Therapeutics Inc 167.14%$ 167.144 millions
Macrogenics Inc 166.47%$ 166.467 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PINS's Profile

Stock Price

PINS's Financials

Business Description

Fundamentals

Charts & Quotes

PINS's News

Suppliers

PINS's Competitors

Customers & Markets

Economic Indicators

PINS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071